Eli Lilly aims for dementia drug candidate’s approval in 2022; wants to ‘prioritize access’
By
Alicia Lasek
Aug 04, 2021
The Alzheimer’s disease-modifying drug donanemab is on track to be considered for full FDA approval by 2022, its developer said.
Clinical briefs for Wednesday, Aug. 4
By
Alicia Lasek
Aug 04, 2021
Genesis HealthCare requires shots for all: Employees, care partners, onsite vendors must be vaccinated … More than half of U.S. outpatient antibiotics prescriptions not tied to visit or infection …...
Long-term care facility docs vs. aides: CDC study finds wide vaccination gulf
By
Alicia Lasek
Aug 03, 2021
There is a 30% difference in COVID-19 vaccination coverage between LTC physicians and facility aides, CDC reports. And rates among aides are lowest in zip codes where vulnerability to poor health outcomes...
Feds approve Regeneron’s antibody therapy as COVID-19 preventive
By
Alicia Lasek
Aug 03, 2021
REGEN-COV now can be used after exposure to the SARS-CoV-2 virus to prevent severe illness in people at high risk of poor outcomes from COVID-19.
The more sports-watching, the lower seniors’ depression risk: study
By
Alicia Lasek
Aug 03, 2021
There is a new reason to binge-watch the Olympic Games. Older adults are less likely to be depressed the more they watch sports — either live or on screen, a new study has found.
Clinical briefs for Tuesday, Aug. 3
By
Alicia Lasek
Aug 03, 2021
SNF recovery threatened by spread of delta variant: LTC exec … Nursing home COVID-19 outbreaks rising again in hot spots … Massachusetts outbreak prompts CDC to suggest re-upped pandemic mitigation...
Adults 65 and older are in a lot of pain, particularly back pain, CDC learns
By
Alicia Lasek
Jul 30, 2021
Nearly 60% of adults reported experiencing chronic physical pain in 2019, with seniors having much of the burden. Women, non-Hispanic white adults, and people with incomes well below the poverty line were...
FDA OKs new insulin biosimilar for type 2 diabetes
By
Alicia Lasek
Jul 30, 2021
Semglee is a safe and more cost-effective alternative to the drug Lantus (insulin glargine), the agency announced Wednesday. Semglee does not need a prescriber’s input to be substituted at the pharmacy.
Shorter course of antibiotics effective in men with UTI, comparison shows
By
Alicia Lasek
Jul 30, 2021
A seven-day course of antibiotics is no less effective than a 14-day course for resolving urinary tract infections in men with no fever, a new study finds.
Clinical briefs for Friday, July 30
By
Alicia Lasek
Jul 30, 2021
AHCA / NCAL back mandatory COVID-19 vaccinations for healthcare workers … Vaccinated but exposed to virus? Get tested, CDC now recommends … Aduhelm’s developer begins a real-world study of controversial...